Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

109 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Active, not recruiting

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

NCT05270668

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease, +7 more
Locations
  • Mayo Clinic - Scottsdale ( Site 4014) Phoenix, Arizona, United States
  • Pacific Arthritis Care Center ( Site 4008) Los Angeles, California, United States
  • Cedars Sinai Medical Center ( Site 4010) Los Angeles, California, United States
  • UCLA School of Medicine ( Site 4006) Los Angeles, California, United States
View all 95 locations
View Trial Details
Active, not recruiting

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

NCT06655896

Conditions
Connective Tissue Diseases, Scleroderma, Diffuse, Scleroderma, Systemic, +2 more
Locations
  • UCLA Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Sutter Health Network San Pablo, California, United States
  • FL Medical Clinic Orlando Health Zephyrhills, Florida, United States
View all 93 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

NCT06025578

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +23 more
Locations
  • Local Institution - 0046 Birmingham, Alabama, United States
  • Local Institution - 0314 Phoenix, Arizona, United States
  • Local Institution - 0336 La Jolla, California, United States
  • Local Institution - 0212 Los Angeles, California, United States
View all 459 locations
View Trial Details
Completed

Brentuximab Vedotin for Systemic Sclerosis

NCT03222492

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, +5 more
Locations
  • UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States
  • Georgetown University Medical Center: Division of Rheumatology Washington D.C., District of Columbia, United States
  • University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology Ann Arbor, Michigan, United States
  • Hospital for Special Surgery, New York: Division of Rheumatology New York, United States
View Trial Details

Related conditions